Hu Xiao-Ting, Song Hao-Chang, Yu Hui, Wu Zu-Chun, Liu Xin-Guang, Chen Wei-Chun
Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Aging Research, Institute of Biochemistry & Molecular Biology, Guangdong Medical University, Dongguan, Guangdong, People's Republic of China.
Onco Targets Ther. 2020 Mar 30;13:2629-2642. doi: 10.2147/OTT.S237016. eCollection 2020.
The accumulation of progerin (PG) in patients is responsible for the pathogenesis of Hutchinson-Gilford Progeria Syndrome (HGPS) because it triggers accelerated aging of cells. However, there are few studies on the effects of progerin on tumor cells. Lung cancer is one of the most common malignant cancers with high global morbidity and mortality rates; non-small cell lung cancer accounts for the majority of cases. The purpose of this study was to determine the effects of progerin on A549 cell proliferation, cell cycle, invasion, migration, sensitivity to DNA damaging agents, senescence and apoptosis with a goal of exploring new ideas for lung cancer treatment.
A549 cells overexpressing progerin (A549-PG) and a corresponding blank control (A549-GFP) were constructed by lentiviral infection. A nuclear staining assay was utilized to detect abnormal nuclear morphology. The proliferation, cell cycle, colony formation, invasion and migration abilities of A549-PG were compared with those of A549-GFP via EdU assays, flow cytometry, colony formation experiments, and Matrigel invasion and migration assays, respectively. SA-β-gal staining was used to measure senescence in cells.
The expression of progerin was significantly higher in A549-PG than A549-GFP. About 20% of A549-PG possessed abnormal nuclei. Overexpression of progerin in A549 cells inhibited cell proliferation, migration and invasion, and associated proteins (CDK4, pRB, ANLN, MMP7 and MMP9) were downregulated. DNA damage repair was also impaired. Progerin did not cause cells to senesce, and there was no difference in apoptosis.
A549-PG generated some cellular changes, including the nuclear skeleton, the cell cycle, DNA damage repair, and migration and invasion abilities. Our data indicate that progerin could cause an imbalance in the steady state in A549 cells and increase their sensitivity to chemotherapeutic drugs.
早衰蛋白(PG)在患者体内的积累是哈钦森-吉尔福德早衰综合征(HGPS)发病机制的原因,因为它会引发细胞加速衰老。然而,关于早衰蛋白对肿瘤细胞影响的研究较少。肺癌是全球发病率和死亡率都很高的最常见恶性肿瘤之一;非小细胞肺癌占大多数病例。本研究的目的是确定早衰蛋白对A549细胞增殖、细胞周期、侵袭、迁移、对DNA损伤剂的敏感性、衰老和凋亡的影响,以期探索肺癌治疗的新思路。
通过慢病毒感染构建过表达早衰蛋白的A549细胞(A549-PG)和相应的空白对照(A549-GFP)。利用核染色试验检测异常核形态。分别通过EdU试验、流式细胞术、集落形成实验以及基质胶侵袭和迁移试验,将A549-PG的增殖、细胞周期、集落形成、侵袭和迁移能力与A549-GFP进行比较。用SA-β-半乳糖苷酶染色检测细胞衰老。
A549-PG中早衰蛋白的表达明显高于A549-GFP。约20%的A549-PG具有异常细胞核。A549细胞中早衰蛋白的过表达抑制了细胞增殖、迁移和侵袭,相关蛋白(CDK4、pRB、ANLN、MMP7和MMP9)下调。DNA损伤修复也受到损害。早衰蛋白未导致细胞衰老,凋亡方面也无差异。
A549-PG产生了一些细胞变化,包括核骨架、细胞周期、DNA损伤修复以及迁移和侵袭能力。我们的数据表明,早衰蛋白可能导致A549细胞稳态失衡,并增加其对化疗药物的敏感性。